跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,629 条关于
“Marathon Beteiligungs AG”
全部
1,629
临床试验
415
药物
379
机构
286
资讯
549
12个月前
Nuclide Therapeutics Secures £5M to Advance ALDH1A1-Targeted Radiotheranostics for Therapy-Resistant Cancers
3个月前
Marathon Running Triggers Acute Cardiac Biomarker Spikes and Structural Changes, but Long-Term Clinical Significance Remains Unclear
去年
Fabhalta Demonstrates Sustained Efficacy in Phase III C3 Glomerulopathy Trial
去年
Formycon's Aflibercept Biosimilar, AHZANTIVE®/Baiama®, Receives Positive CHMP Opinion for EU Approval
2年前
4SC AG Receives MHRA Waiver for Resminostat in Pediatric CTCL
3年前
4SC's Resminostat Advances Towards European Market Approval for CTCL Maintenance Therapy
2年前
Telemedicine Study Accelerates for Pediatric Ear Conditions, Showing Promise for Reduced Wait Times
4年前
RESMAIN Study: Resminostat Shows Promise in Cutaneous T-Cell Lymphoma Maintenance
6年前
RESMAIN Trial of Resminostat for CTCL Maintenance Continues After Positive Safety Review
4个月前
908 Devices Acquires NIRLAB AG to Strengthen Narcotics Detection Capabilities
第 1 页,共 55 页
上一页
下一页